Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis [Phase 2]

View source ↗

Summary

UNION Therapeutics completed a Phase 2 trial evaluating the safety and efficacy of ATx201 in adults with moderate atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ATx201

Snippet

Sponsor: UNION therapeutics | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED